Leica BOND Antibody CDX2 Recall: Product May Not Perform as Specified
Leica Microsystems recalls BOND Ready-To-Use Primary Antibody CDX2 (EP25) REF PA0375 due to potential performance issues. Affected units may not function correctly as per instructions.
Lower-risk recall
Product may not perform as specified in IFU.
Contact the company
What happened, in plain English
Leica Microsystems is recalling a specific antibody product because it might not work properly as described in the user manual. This could affect lab results or experiments if the product doesn't perform as intended. Read more at govinfonow.com/recall/62111-leica-bond-antibody-cdx2-recall-product-may-not-perform-as.
Source Summary by GovInfoNow · govinfonow.com/recall/62111-leica-bond-antibody-cdx2-recall-product-may-not-perform-as · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2481-2021
Cite this page
“Leica BOND Antibody CDX2 Recall: Product May Not Perform as Specified.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62111-leica-bond-antibody-cdx2-recall-product-may-not-perform-as. Based on FDA recall #Z-2481-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2481-2021%22&limit=1).
Why it’s dangerous
The product may not function correctly as specified in the user manual. This could lead to inaccurate lab results or failed experiments if the antibody doesn't perform as intended.
Who’s affected
Lab researchers and scientists using this antibody product in their work. Those who have the specific product code PA0375 are most at risk.
How to tell if you have this one
Check for the product code PA0375 and lot number 69909 on the label. The product is a Ready-To-Use Primary Antibody CDX2 (EP25) from Leica Microsystems.
- Brand
Leica- Category
Medical device
What to do — step by step
Check Product Details
Look for the product code PA0375 and lot number 69909 on the label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 23 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product dangerous?
The recall states the product may not perform as specified in the user manual, but it does not indicate a safety hazard like injury or fire. This is a performance issue, not a safety risk.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2481-2021 (July 30, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2481-2021 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.